Melanoma Journal Articles for June 2019
Journal of Cancer Survivorship
The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors
Julia Lai-Kwon, Chloe Khoo, Serigne Lo, Donna Milne, Mustafa Mohamed, Jeanette Raleigh, Kortnye Smith, Karolina Lisy, Shahneen Sandhu, Michael Jefford
Original Research
First Online: 04 June 2019
(https://doi.org/10.1007/s11764-019-00770-0)
The lancet
Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB–C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial
Prof Georgina V Long, PhD , Robyn P M Saw, MS, Serigne Lo, PhD, Prof Omgo E Nieweg, PhD, Kerwin F Shannon, MBBS, Maria Gonzalez, MHlthSc, et al.
Published:June 03, 2019DOI: https://doi.org/10.1016/S1470-2045(19)30331-6
New England Journal of Medicine
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
Caroline Robert, M.D., Ph.D., Jean J. Grob, M.D., Ph.D., Daniil Stroyakovskiy, M.D., Boguslawa Karaszewska, M.D., Axel Hauschild, M.D., Evgeny Levchenko, M.D., Vanna Chiarion Sileni, M.D., Jacob Schachter, M.D., Claus Garbe, M.D., Igor Bondarenko, M.D., Ph.D., Helen Gogas, M.D., Mario Mandalá, M.D., et al.
June 4, 2019
DOI: 10.1056/NEJMoa1904059
Dove Press
Photothermal effects of NaYF4:Yb,Er@PE3@Fe3O4superparamagnetic nanoprobes in the treatment of melanoma
Authors Wang X, Kang C, Pan Y, Jiang R
Received 27 January 2019
Accepted for publication 1 May 2019
Published 10 June 2019 Volume 2019:14 Pages 4319—4331
DOI https://doi.org/10.2147/IJN.S203077
Cancer Research
Embryonic stem cell microenvironment suppresses the malignancy of cutaneous melanoma cells by down?regulating PI3K/AKT pathway
Chenjie Wang, Xiaoran Wang, Jiahui Liu, Zheqian Huang, Chaoyang Li, Ying Liu, Xuan Sang, Liu Yang, Shoubi Wang, Yaru Su, Chengxiu Liu, Yizhi Liu, Zhichong Wang
First published: 07 June 2019, https://doi.org/10.1002/cam4.2207
iOVS
Heterogeneity in Mitogen-Activated Protein Kinase (MAPK) Pathway Activation in Uveal Melanoma With Somatic GNAQ and GNA11 Mutations
Getachew Boru; Colleen M. Cebulla; Klarke M. Sample; James B. Massengill; Frederick H. Davidorf; Mohamed H. Abdel-Rahman
Investigative Ophthalmology & Visual Science June 2019, Vol.60, 2474-2480. doi:10.1167/iovs.18-26452
Dove Press
Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression
Authors Wang M, Xu Y, Wen GZ, Wang Q, Yuan SM
Received 13 February 2019
Accepted for publication 26 April 2019
Published 13 June 2019 Volume 2019:12 Pages 4643—4654
DOI https://doi.org/10.2147/OTT.S205160
Dove Press
Studies on the treatment of melanoma with folate acid conjugated dextran and lauryl alcohol loaded with IMD0354
Authors Liu C, Chen W, Chen Z, Yan Y, Wang Q, Xie H, Chen X, Wang A, Tang S, Zhou J
Received 5 March 2019
Accepted for publication 27 April 2019
Published 14 June 2019 Volume 2019:12 Pages 4655—4663
DOI https://doi.org/10.2147/OTT.S207685
The Lancet
Paediatric melanoma: clinical update, genetic basis, and advances in diagnosis
Emily A Merkel, MD, Lauren S Mohan, MSc, Katherine Shi, BS, Elnaz Panah, MD, Bin Zhang, MS, Pedram Gerami, MD
Published:June 13, 2019DOI: https://doi.org/10.1016/S2352-4642(19)30116-6
The Lancet
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
Prof Georgina V Long, PhD, Prof Reinhard Dummer, MD, Omid Hamid, MD, Prof Thomas F Gajewski, MD, Christian Caglevic, MD, Prof Stephane Dalle, MD, et al.
Published:June 17, 2019DOI:https://doi.org/10.1016/S1470-2045(19)30274-8
SN Applied Sciences
Feature extraction from dermoscopy images for melanoma diagnosis
Sharmin MajumderMuhammad Ahsan Ullah
- Research Article
- First Online: 20 June 2019
Cancer Medicine
Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study
Antonio Tejera?Vaquerizo, Simone Ribero, Susana Puig, Aram Boada, Sabela Paradela, David Moreno?Ramírez, Javier Cañueto, Blanca de Unamuno, Ana Brinca, et.al.
First published: 18 June 2019
https://doi.org/10.1002/cam4.2358
Cancer medicine
Melanoma incidence, recurrence, and mortality in an integrated healthcare system: A retrospective cohort study
Heather S. Feigelson, John D. Powers, Mayanka Kumar, Nikki M. Carroll, Arun Pathy, Debra P. Ritzwoller
First published: 19 June 2019
https://doi.org/10.1002/cam4.2252
Original Investigation
June 26, 2019
Comparison of Survival Between Patients With Single vs Multiple Primary Cutaneous Melanomas
Mary-Ann El Sharouni, MD1; Arjen J. Witkamp, MD, PhD2; Vigfús Sigurdsson, MD, PhD1; et alPaul J. van Diest, MD, PhD3
JAMA Dermatol. Published online June 26, 2019. doi:10.1001/jamadermatol.2019.1134
Anatomy and Pathology/Oncology | June 2019
Conjunctival Melanoma Targeted Therapy: MAPK and PI3K/mTOR Pathways Inhibition
Ikram El Zaoui; Maya Bucher; Donata Rimoldi; Michael Nicolas; Gurkan Kaya; Rosanna Pescini Gobert; Nicola Bedoni; Ann Schalenbourg; Ezziat Sakina; Leonidas Zografos; Serge Leyvraz; Nicolo Riggi; Carlo Rivolta; Alexandre P. Moulin
Investigative Ophthalmology & Visual Science June 2019, Vol.60, 2764-2772. doi:10.1167/iovs.18-26508
British Journal of Dermatology
Original Article
Full Access
The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population?based matched cohort study in Korea
H.S. Kim, H.J. Kim, E.S. Hong, K.B. Kim, J.D. Lee, T.U. Kang, H.S. Ahn
First published: 24 June 2019
https://doi.org/10.1111/bjd.18247
Cell Reports
Volume 27, Issue 12, 18 June 2019, Pages 3573-3586.e7
The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma
BengtPhung18MaciejCie?la28AdrianaSanna1NicolaGuzzi2GiuliaBeneventi2PhuongCao Thi Ngoc2MartinLauss1RitaCabrita1EugeniaCordero3AnaBosch1FridaRosengren1JariHäkkinen1KlausGriewank4AnnettePaschen4KatjaHarbst1HåkanOlsson1ChristianIngvar5AnaCarneiro16…GöranJönsson191011
https://doi.org/10.1016/j.celrep.2019.05.069